Sentences with phrase «prices over the timeframes»

The black lines on the graph are plotting monthly closing stock prices over the timeframes presented.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

This indicator helps you measure how volume fluctuates with a particular stock, relative to its price over a certain timeframe.

Drilling down to the weekly chart timeframe below, we get a better idea of how the market's price action could play out over the next several weeks.

This transient view of inflation ignores the fact that if wages / salaries didn't increase by 100 % over the 3 year timeframe in my example then people are permanently affected by the increase in house prices (unless and until their wages catch up).

Deep cuts in emissions will require signals that the CO2 price at $ 30 or above is here to stay and that the caps on emissions will be imposed and become ever stricter each year over decadal timeframes.

On the other hand, since April of 2014 the disconnect between stock price and earnings appears more pronounced than at any other time over this long - term timeframe.

The key fact is that over timeframes above a year, both performance and prices tend to mean revert.

Since going public in 1992, Starbucks» stock price has risen over 16,000 %, crushing the S&P's 486 % return over the same timeframe.

Deep cuts in emissions will require signals that the CO2 price at $ 30 or above is here to stay and that the caps on emissions will be imposed and become ever stricter each year over decadal timeframes.

• Midwest is hit hard, with deeper depreciation in prices over quarterly and yearly timeframes.